Completed NA INTERVENTIONAL 1-arm NCT05819502

Profile HIT (Holistic Individualized Treatment) (HIT-PRF)

A Prospective Clinical Trial Evaluating the Profile HIT (Holistic Individualized Treatment)

Sponsor: Erevna Innovations Inc.

Conditions Aesthetic

Interventions Restylane line of injectables

Updated 7 times since 2023 Last updated: Feb 3, 2025 Started: Mar 20, 2023 Primary completion: Feb 24, 2024 Completion: Mar 24, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Aesthetic and is currently completed. Erevna Innovations Inc. leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Mar 2025 — Present [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Sep 2024 — Mar 2025 [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Active Not Recruiting NA
May 2024 — Jun 2024 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Jun 2023 — May 2024 [monthly]

Recruiting NA
May 2023 — Jun 2023 [monthly]

Recruiting NA

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erevna Innovations Inc.

Data source: Erevna Innovations Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada